$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 5, 2025)
$320.42M
Market Cap
-
P/E Ratio
-2.25
EPS
$15.25
52 Week High
$3.35
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Contineum Therapeutics, Inc. is a clinical-stage biopharmaceutical company located in San Diego, California, focused on developing innovative oral small molecule therapies to address significant unmet medical needs in neuroscience, inflammation, and immunology. The company boasts a robust pipeline driven by advanced research capabilities and a commitment to scientific excellence, positioning itself to deliver effective treatments that enhance patient outcomes. With a strategic focus on addressing critical healthcare challenges, Contineum is poised for substantial growth within the biopharmaceutical industry, making it an attractive prospect for institutional investors.
LPTX
WBD
IRBT
NVDA
SOFI
NFLX
ASST
BYND
INTC
PLUG
IPG
VALE
VHAI
ITUB
AAL
TSLA
DBRG
F
RGTI
ADAP
DNN
BITF
HPE
RR
PFE
GRAB
PBR
NFE
KEY
QBTS
MARA
NIO
BAC
SNAP
AMD
CLSK
DVLT
PLTR
TNFA
MTSR
T
GOOGL
IREN
APLD
PLTD
SMR
VZ
HBAN
CIFR
AVGO
CGC
BTBT
WMT
ORCL
AGNC
HOOD
MSFT
HIMS
PMCB
TWNP
MRVL
LPTX
WBD
IRBT
NVDA
SOFI
NFLX
ASST
BYND
INTC
PLUG
IPG
VALE
VHAI
ITUB
AAL
TSLA
DBRG
F
RGTI
ADAP
DNN
BITF
HPE
RR
PFE
GRAB
PBR
NFE
KEY
QBTS
MARA
NIO
BAC
SNAP
AMD
CLSK
DVLT
PLTR
TNFA
MTSR
T
GOOGL
IREN
APLD
PLTD
SMR
VZ
HBAN
CIFR
AVGO
CGC
BTBT
WMT
ORCL
AGNC
HOOD
MSFT
HIMS
PMCB
TWNP
MRVL